These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9483761)

  • 1. [The reciprocally modifying effect of schizophrenia and diabetes mellitus on their phenotypic manifestations].
    Dvirskiĭ AA
    Tsitol Genet; 1997; 31(5):67-70. PubMed ID: 9483761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.
    Cohen D; Dekker JJ; Peen J; Gispen-de Wied CC
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):187-94. PubMed ID: 16263247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Schizophrenia and diabetes mellitus: not an improbable combination].
    Cohen D; Gispen-de Wied CC
    Ned Tijdschr Geneeskd; 2003 May; 147(21):993-6. PubMed ID: 12811967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of type II diabetes mellitus is haptoglobin phenotype-independent.
    Awadallah S; Hamad M
    Cytobios; 2000; 101(398):145-50. PubMed ID: 10755213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of schizophrenia in a nationwide cohort of patients with type 1 diabetes mellitus.
    Juvonen H; Reunanen A; Haukka J; Muhonen M; Suvisaari J; Arajärvi R; Partonen T; Lönnqvist J
    Arch Gen Psychiatry; 2007 Aug; 64(8):894-9. PubMed ID: 17679634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband.
    Tripathy D; Lindholm E; Isomaa B; Saloranta C; Tuomi T; Groop L
    Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1297-303. PubMed ID: 12954593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?
    Gough SC; O'Donovan MC
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):47-55. PubMed ID: 16280337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA polymorphism analysis of candidate genes for type 2 diabetes mellitus in a Mexican ethnic group.
    Flores-Martínez SE; Islas-Andrade S; Machorro-Lazo MV; Revilla MC; Juárez RE; Mújica-López KI; Morán-Moguel MC; López-Cardona MG; Sánchez-Corona J
    Ann Genet; 2004; 47(4):339-48. PubMed ID: 15581831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E; Hallengren B; Agardh CD
    Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
    Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
    Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E polymorphism and clinical disease phenotypes in Arab patients with schizophrenia.
    Akanji AO; Ohaeri JU; Al-Shammri SN; Fatania HR
    Neuropsychobiology; 2009; 60(2):67-72. PubMed ID: 19752580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenic women with the APOE epsilon 4 allele have a worse prognosis than those without it.
    Martorell L; Virgos C; Valero J; Coll G; Figuera L; Joven J; Pocoví M; Labad A; Vilella E
    Mol Psychiatry; 2001 May; 6(3):307-10. PubMed ID: 11326299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus in patients with schizophrenia in Taiwan.
    Hung CF; Wu CK; Lin PY
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):523-7. PubMed ID: 15866353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SPINK1 N34S mutation is not associated with Type 2 diabetes mellitus in a population of the USA.
    Schneider A; Lawrence EC; Barmada MM; Norris JM; Hamman RF; Marshall JA; Ferrell RE; Whitcomb DC
    Diabet Med; 2005 Jun; 22(6):744-8. PubMed ID: 15910626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of malignancies in patients with insulin-treated diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN).
    Schiel R; Müller UA; Braun A; Stein G; Kath R
    Eur J Med Res; 2005 Aug; 10(8):339-44. PubMed ID: 16131475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The incidence of ocular complications in 10,000 diabetes mellitus patients hospitalized at Dolj County Clinical Hospital].
    Ignat F; Mocanu C; Davidescu L; Poştaliu D
    Oftalmologia; 2000; 51(2):62-9. PubMed ID: 11021125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and 7-year incidence of Type II diabetes mellitus in a Japanese-Brazilian population: an alarming public health problem.
    Gimeno SG; Ferreira SR; Franco LJ; Hirai AT; Matsumura L; Moisés RS
    Diabetologia; 2002 Dec; 45(12):1635-8. PubMed ID: 12488952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetic retinopathy in newly diagnosed patients with type II diabetes mellitus].
    Tălu S; Kaucsar E; Soreanu A
    Oftalmologia; 2002; 54(3):27-30. PubMed ID: 12723193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-insulin dependent diabetes mellitus during development in the population ].
    Buczkowska EO; Chobot PJ
    Wiad Lek; 2001; 54(3-4):192-201. PubMed ID: 11436686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.